117 related articles for article (PubMed ID: 33421131)
1. A novel strategy for engineering of a smart generation of immune ribonucleases against EGFR
Taghizadegan N; Firoozrai M; Nassiri M; Ariannejad H
J Cell Physiol; 2021 Jun; 236(6):4303-4312. PubMed ID: 33421131
[TBL] [Abstract][Full Text] [Related]
2. Production and introduction of a novel immunotoxin based on engineered RNase A for inducing death to Her1-positive cell lines.
Forouharmehr A; Nassiri M; Ghovvati Roudsari S; Javadmanesh A
J Cell Physiol; 2020 May; 235(5):4679-4687. PubMed ID: 31663127
[TBL] [Abstract][Full Text] [Related]
3. Construction, expression, and activity of a novel immunotoxin comprising a humanized antiepidermal growth factor receptor scFv and modified Pseudomonas aeruginosa exotoxin A.
Akbari B; Farajnia S; Zarghami N; Mahdieh N; Rahmati M; Khosroshahi SA; Barzegar A; Rahbarnia L
Anticancer Drugs; 2017 Mar; 28(3):263-270. PubMed ID: 27861173
[TBL] [Abstract][Full Text] [Related]
4. Novel EGFR-specific immunotoxins based on panitumumab and cetuximab show in vitro and ex vivo activity against different tumor entities.
Niesen J; Stein C; Brehm H; Hehmann-Titt G; Fendel R; Melmer G; Fischer R; Barth S
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2079-95. PubMed ID: 25899161
[TBL] [Abstract][Full Text] [Related]
5. A novel EGFR-specific recombinant ricin-panitumumab (scFv) immunotoxin against breast and colorectal cancer cell lines; in silico and in vitro analyses.
Naemi AA; Salmanian AH; Noormohammadi Z; Amani J
Eur J Pharmacol; 2023 Sep; 955():175894. PubMed ID: 37429519
[TBL] [Abstract][Full Text] [Related]
6. A fusogenic dengue virus-derived peptide enhances antitumor efficacy of an antibody-ribonuclease fusion protein targeting the EGF receptor.
Kiesgen S; Liebers N; Cremer M; Arnold U; Weber T; Keller A; Herold-Mende C; Dyckhoff G; Jäger D; Kontermann RE; Arndt MA; Krauss J
Protein Eng Des Sel; 2014 Oct; 27(10):331-7. PubMed ID: 25301960
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor-dependent cytotoxic effect by an EGF-ribonuclease conjugate on human cancer cell lines--a trial for less immunogenic chimeric toxin.
Jinno H; Ueda M; Ozawa S; Kikuchi K; Ikeda T; Enomoto K; Kitajima M
Cancer Chemother Pharmacol; 1996; 38(4):303-8. PubMed ID: 8674151
[TBL] [Abstract][Full Text] [Related]
8. Gigantoxin-4-4D5 scFv is a novel recombinant immunotoxin with specific toxicity against HER2/neu-positive ovarian carcinoma cells.
Lv X; Zhang J; Xu R; Dong Y; Sun A; Shen Y; Wei D
Appl Microbiol Biotechnol; 2016 Jul; 100(14):6403-6413. PubMed ID: 27063011
[TBL] [Abstract][Full Text] [Related]
9. Construction and characterization of the recombinant immunotoxin RTA-4D5-KDEL targeting HER2/neu-positive cancer cells and locating the endoplasmic reticulum.
Jiao P; Zhang J; Dong Y; Wei D; Ren Y
Appl Microbiol Biotechnol; 2018 Nov; 102(22):9585-9594. PubMed ID: 30141083
[TBL] [Abstract][Full Text] [Related]
10. Preparation of a novel EGFR specific immunotoxin and its efficacy of anti-colorectal cancer in vitro and in vivo.
Wu S; Deng C; Zhang C; Xiong J; Gu X; Wang Z; Tu J; Xie J
Clin Transl Oncol; 2021 Aug; 23(8):1549-1560. PubMed ID: 33474678
[TBL] [Abstract][Full Text] [Related]
11. The efficient elimination of solid tumor cells by EGFR-specific and HER2-specific scFv-SNAP fusion proteins conjugated to benzylguanine-modified auristatin F.
Woitok M; Klose D; Niesen J; Richter W; Abbas M; Stein C; Fendel R; Bialon M; Püttmann C; Fischer R; Barth S; Kolberg K
Cancer Lett; 2016 Oct; 381(2):323-30. PubMed ID: 27502168
[TBL] [Abstract][Full Text] [Related]
12. A novel Carcinoembryonic Antigen (CEA)-Targeted Trimeric Immunotoxin shows significantly enhanced Antitumor Activity in Human Colorectal Cancer Xenografts.
Lázaro-Gorines R; Ruiz-de-la-Herrán J; Navarro R; Sanz L; Álvarez-Vallina L; Martínez-Del-Pozo A; Gavilanes JG; Lacadena J
Sci Rep; 2019 Aug; 9(1):11680. PubMed ID: 31406218
[TBL] [Abstract][Full Text] [Related]
13. Construction and expression of single-chain antibody derived from a new clone of monoclonal antibody against human CD14 in CHO cells.
Tang YM; Ning BT; Cao J; Shen HQ; Qian BQ
Immunopharmacol Immunotoxicol; 2007; 29(3-4):375-86. PubMed ID: 18075851
[TBL] [Abstract][Full Text] [Related]
14. Anti-Metastatic Activity of an Anti-EGFR Monoclonal Antibody against Metastatic Colorectal Cancer with
Ohishi T; Kato Y; Kaneko MK; Ohba SI; Inoue H; Harakawa A; Kawada M
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32839411
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor effect of single-chain antibody to Reg3a in colorectal cancer.
Du P; Wang X; Yin T; Zhang X; Zhang Z; Yu W; Wang M; Luo C; Yu L
Exp Cell Res; 2020 Nov; 396(1):112278. PubMed ID: 32918897
[TBL] [Abstract][Full Text] [Related]
16. A fully human antitumor immunoRNase selective for ErbB-2-positive carcinomas.
De Lorenzo C; Arciello A; Cozzolino R; Palmer DB; Laccetti P; Piccoli R; D'Alessio G
Cancer Res; 2004 Jul; 64(14):4870-4. PubMed ID: 15256457
[TBL] [Abstract][Full Text] [Related]
17. Inclusion of a furin-sensitive spacer enhances the cytotoxicity of ribotoxin restrictocin containing recombinant single-chain immunotoxins.
Goyal A; Batra JK
Biochem J; 2000 Jan; 345 Pt 2(Pt 2):247-54. PubMed ID: 10620501
[TBL] [Abstract][Full Text] [Related]
18. Human antibody RNase fusion protein targeting CD30+ lymphomas.
Menzel C; Schirrmann T; Konthur Z; Jostock T; Dübel S
Blood; 2008 Apr; 111(7):3830-7. PubMed ID: 18230757
[TBL] [Abstract][Full Text] [Related]
19. Expression and fast preparation of biologically active recombinant human coagulation factor VII in CHO-K1 cells.
Xiao W; Li CQ; Xiao XP; Lin FZ
Genet Mol Res; 2013 Dec; 12(4):6813-24. PubMed ID: 24391029
[TBL] [Abstract][Full Text] [Related]
20. Sialic Acid-Binding Lectin from Bullfrog Eggs Exhibits an Anti-Tumor Effect Against Breast Cancer Cells Including Triple-Negative Phenotype Cells.
Tatsuta T; Sato S; Sato T; Sugawara S; Suzuki T; Hara A; Hosono M
Molecules; 2018 Oct; 23(10):. PubMed ID: 30347895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
